Back

WNT11 suppresses tumor initiation and invasion by inactivating RAC1

Karthikeyan, S.; Casey, P.; Wang, M.

2026-07-15 cancer biology
10.64898/2026.07.13.738348 bioRxiv
Show abstract

WNT11, a non-canonical WNT ligand, plays well-defined roles in development and tissue architecture; however, its function in cancer remains ambiguous. Here, we characterize WNT11 as a context-dependent suppressor of cancer stemness, invasion, and in vivo tumor formation in human epithelial cancer models. We show that WNT11 upregulation reduces the expression of stemness-promoting genes, suppresses epithelial-to-mesenchymal transition, and inhibits sphere formation and tumor growth. Conversely, downregulation of WNT11 enhances these aggressive malignant properties of cancer cells. Mechanistically, we found that the ability of WNT11 to inhibit RAC1 GTPase activation is essential for its regulation of invasion and self-renewal. In cells unresponsive to WNT11, the connectivity between WNT11 and RAC1 activity is disengaged. Direct manipulation of RAC1 activity in these cells recapitulates the phenotype and molecular signature of WNT11-responsive cells, establishing RAC1 as a critical effector of WNT11-mediated tumor suppression. Taken together, these findings identify the cellular context in which WNT11 suppresses RAC1 activation as a key determinant of its anti-tumor effects and provide a mechanistic framework for understanding the diverse, and sometimes opposing, roles of WNT11 reported in cancer.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 4%
26.4%
2
Cell Reports
1498 papers in training set
Top 3%
7.8%
3
Cancer Research
130 papers in training set
Top 0.5%
6.2%
4
eLife
5828 papers in training set
Top 21%
5.5%
5
Oncogene
85 papers in training set
Top 0.3%
5.4%
50% of probability mass above
6
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 11%
4.8%
7
EMBO Reports
263 papers in training set
Top 2%
2.6%
8
Nature
645 papers in training set
Top 5%
2.4%
9
Cancer Discovery
66 papers in training set
Top 0.9%
2.4%
10
Science Signaling
65 papers in training set
Top 0.5%
2.1%
11
The EMBO Journal
309 papers in training set
Top 3%
2.0%
12
Developmental Cell
196 papers in training set
Top 2%
1.9%
13
Science Advances
1243 papers in training set
Top 19%
1.7%
14
Molecular Cancer Research
49 papers in training set
Top 0.7%
1.7%
15
Cell Communication and Signaling
51 papers in training set
Top 0.9%
1.1%
16
Molecular and Cellular Biology
47 papers in training set
Top 0.6%
1.1%
17
Cell Death & Disease
21 papers in training set
Top 0.3%
1.1%
18
Journal of Cell Biology
392 papers in training set
Top 3%
1.1%
19
Cancers
213 papers in training set
Top 4%
1.1%
20
Communications Biology
993 papers in training set
Top 22%
1.1%
21
Scientific Reports
3612 papers in training set
Top 68%
1.1%
22
Nature Ecology & Evolution
18 papers in training set
Top 0.4%
0.8%
23
Journal of Clinical Investigation
179 papers in training set
Top 6%
0.8%
24
Nature Genetics
286 papers in training set
Top 5%
0.6%
25
Science Translational Medicine
127 papers in training set
Top 4%
0.6%
26
PLOS Biology
486 papers in training set
Top 14%
0.6%
27
Molecular Cancer Therapeutics
40 papers in training set
Top 1.0%
0.6%
28
JCI Insight
277 papers in training set
Top 9%
0.6%
29
PLOS Genetics
862 papers in training set
Top 14%
0.6%